Jean‐Jacques Lebrun

4.4k total citations
68 papers, 3.6k citations indexed

About

Jean‐Jacques Lebrun is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jean‐Jacques Lebrun has authored 68 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 35 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Jean‐Jacques Lebrun's work include TGF-β signaling in diseases (29 papers), Cancer Cells and Metastasis (12 papers) and Cancer-related Molecular Pathways (11 papers). Jean‐Jacques Lebrun is often cited by papers focused on TGF-β signaling in diseases (29 papers), Cancer Cells and Metastasis (12 papers) and Cancer-related Molecular Pathways (11 papers). Jean‐Jacques Lebrun collaborates with scholars based in Canada, United States and United Arab Emirates. Jean‐Jacques Lebrun's co-authors include Suhad Ali, Paul A. Kelly, Wylie Vale, Jean-Charles Neel, Laure Humbert, Eftihia Cocolakis, Yan Chen, Lucie Canaff, Sajid Ali and Isabelle Pellegrini and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Jean‐Jacques Lebrun

68 papers receiving 3.5k citations

Peers

Jean‐Jacques Lebrun

ONCOL

EDM

IMMUN

Hippokratis Kiaris United States

Masatoshi Ichihara Japan

Corinne Bousquet France

Andrea Morrione United States

Yoshiki Murakumo Japan

Senén Vilaró Spain

Bassem R. Haddad United States

Baoan Ji United States

Francesco Trapasso United States

Hippokratis Kiaris United States

Jean‐Jacques Lebrun

1.7k ×0.8

1.2k ×0.9

ONCOL

654 ×1.2

EDM

646 ×1.2

329 ×0.6

IMMUN

Citations per year, relative to Jean‐Jacques Lebrun Jean‐Jacques Lebrun (= 1×) peers Hippokratis Kiaris

Countries citing papers authored by Jean‐Jacques Lebrun

Since Specialization

Citations

This map shows the geographic impact of Jean‐Jacques Lebrun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Jacques Lebrun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Jacques Lebrun more than expected).

Fields of papers citing papers by Jean‐Jacques Lebrun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Jacques Lebrun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Jacques Lebrun. The network helps show where Jean‐Jacques Lebrun may publish in the future.

Co-authorship network of co-authors of Jean‐Jacques Lebrun

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Jacques Lebrun. A scholar is included among the top collaborators of Jean‐Jacques Lebrun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Jacques Lebrun. Jean‐Jacques Lebrun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Xueqing, et al.. (2025). A novel clinically relevant antagonistic interplay between prolactin and oncogenic YAP-CCN2 pathways as a differentiation therapeutic target in breast cancer. Cell Death and Disease. 16(1). 221–221. 2 indexed citations

El‐Awady, Raafat, Maha Saber-Ayad, Ni Wang, et al.. (2024). Targeting the DYRK1A kinase prevents cancer progression and metastasis and promotes cancer cells response to G1/S targeting chemotherapy drugs. npj Precision Oncology. 8(1). 128–128. 2 indexed citations

Yan, Gang, Meiou Dai, Chenjing Zhang, et al.. (2021). TGFβ/cyclin D1/Smad-mediated inhibition of BMP4 promotes breast cancer stem cell self-renewal activity. Oncogenesis. 10(3). 21–21. 18 indexed citations

Dai, Meiou, Gang Yan, Ni Wang, et al.. (2021). In vivo genome-wide CRISPR screen reveals breast cancer vulnerabilities and synergistic mTOR/Hippo targeted combination therapy. Nature Communications. 12(1). 3055–3055. 81 indexed citations

Dai, Meiou, Ni Wang, Gang Yan, et al.. (2020). Differential Regulation of Cancer Progression by CDK4/6 Plays a Central Role in DNA Replication and Repair Pathways. Cancer Research. 81(5). 1332–1346. 32 indexed citations

Hachim, Ibrahim Y., Vanessa M. López‐Ozuna, Mahmood Yaseen Hachim, Jean‐Jacques Lebrun, & Suhad Ali. (2019). Prolactin hormone exerts anti-tumorigenic effects in HER-2 overexpressing breast cancer cells through regulation of stemness. Stem Cell Research. 40. 101538–101538. 15 indexed citations

Tian, Jun, Yun Wang, Meiou Dai, et al.. (2017). KiSS1 gene as a novel mediator of TGFβ-mediated cell invasion in triple negative breast cancer. Cellular Signalling. 42. 1–10. 24 indexed citations

Hachim, Ibrahim Y., Mahmood Yaseen Hachim, Vanessa M. López‐Ozuna, Suhad Ali, & Jean‐Jacques Lebrun. (2016). A dual prognostic role for the TGFβ receptors in human breast cancer. Human Pathology. 57. 140–151. 11 indexed citations

Hachim, Mahmood Yaseen, et al.. (2016). A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome. Human Pathology. 53. 142–152. 31 indexed citations

10.

Liu, Fengming, et al.. (2015). Prolactin/Jak2 directs apical/basal polarization and luminal linage maturation of mammary epithelial cells through regulation of the Erk1/2 pathway. Stem Cell Research. 15(2). 376–383. 26 indexed citations

11.

Guo, Jimin, Lucie Canaff, Charles Vincent Rajadurai, et al.. (2014). Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomes. Breast Cancer Research. 16(6). 476–476. 23 indexed citations

12.

Humbert, Laure, et al.. (2013). Development of buffers for fast semidry transfer of proteins. Analytical Biochemistry. 441(2). 182–184. 9 indexed citations

13.

Dai, Meiou, et al.. (2013). MicroRNA-584 and the Protein Phosphatase and Actin Regulator 1 (PHACTR1), a New Signaling Route through Which Transforming Growth Factor-β Mediates the Migration and Actin Dynamics of Breast Cancer Cells. Journal of Biological Chemistry. 288(17). 11807–11823. 62 indexed citations

14.

Boulais, Étienne, et al.. (2013). Visible and near infrared resonance plasmonic enhanced nanosecond laser optoporation of cancer cells. Biomedical Optics Express. 4(4). 490–490. 34 indexed citations

15.

Neel, Jean-Charles, Laure Humbert, & Jean‐Jacques Lebrun. (2012). The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis. PubMed. 2012. 1–28. 299 indexed citations

16.

Ho, Joanne, et al.. (2003). Activin induces hepatocyte cell growth arrest through induction of the cyclin-dependent kinase inhibitor p15INK4B and Sp1. Cellular Signalling. 16(6). 693–701. 39 indexed citations

17.

Valderrama-Carvajal, Héctor, Eftihia Cocolakis, Annie Lacerte, et al.. (2002). Activin/TGF-β induce apoptosis through Smad-dependent expression of the lipid phosphatase SHIP. Nature Cell Biology. 4(12). 963–969. 138 indexed citations

18.

Lebrun, Jean‐Jacques, Kazuaki Takabe, Yan Chen, & Wylie Vale. (1999). Roles of Pathway-Specific and Inhibitory Smads in Activin Receptor Signaling. Molecular Endocrinology. 13(1). 15–23. 89 indexed citations

19.

Takabe, Kazuaki, Jean‐Jacques Lebrun, Yoji Nagashima, et al.. (1999). Interruption of Activin A Autocrine Regulation by Antisense Oligodeoxynucleotides Accelerates Liver Tumor Cell Proliferation*. Endocrinology. 140(7). 3125–3132. 17 indexed citations

20.

Lebrun, Jean‐Jacques, Suhad Ali, Axel Ullrich, & Paul A. Kelly. (1995). Proline-rich Sequence-mediated Jak2 Association to the Prolactin Receptor Is Required but Not Sufficient for Signal Transduction. Journal of Biological Chemistry. 270(18). 10664–10670. 149 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact